![Li Guang Ma](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Li Guang Ma
Direttore Finanziario/CFO presso Hebei Yipin Pharmaceutical Co., Ltd.
Profilo
Li Guang Ma is currently the Chief Financial Officer & Board Secretary at Hebei Yipin Pharmaceutical Co., Ltd.
Posizioni attive di Li Guang Ma
Società | Posizione | Inizio |
---|---|---|
Hebei Yipin Pharmaceutical Co., Ltd.
![]() Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Direttore Finanziario/CFO | 01/08/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Hebei Yipin Pharmaceutical Co., Ltd.
![]() Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Health Technology |
- Borsa valori
- Insiders
- Li Guang Ma